Andrew is a Principal at SixThirty Ventures.
Andrew focuses on the intersection of digital health and fintech. He previously led teams innovating new treatments in neuro and genitourinary oncology at the Washington University School of Medicine. He subsequently served as Vice President of Strategy and Partnership at Citi Ventures and consulted at Edward Jones, connecting data science and advanced analytics to business growth and insights.
